ADVANCED SOLID CANCERS
Clinical trials for ADVANCED SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test Double-Punch cell therapy to fight tough cancers
Disease control Recruiting nowThis early study is testing a new two-part cell therapy for people with advanced solid cancers that have not responded to standard treatments. It combines two types of modified immune cells—dendritic cells and CAR-T cells—to try to help the immune system find and kill cancer cell…
Matched conditions: ADVANCED SOLID CANCERS
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New cancer drug trial seeks to shrink tough tumors
Disease control Recruiting nowThis early-stage clinical trial is testing a new drug called BNT329 in people with advanced solid cancers that have a specific marker called CA19-9. The main goals are to find the safest and most effective dose and to see if the drug can shrink tumors or stop them from growing. T…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New cancer drug trial aims to stop tumor growth
Disease control Recruiting nowThis study is testing an experimental immunotherapy called PRL3-Zumab in patients with advanced solid cancers that have spread. The trial aims to see if the treatment can safely slow or stop cancer progression for at least six months. About 52 patients will receive intravenous in…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug enters first human testing
Disease control Recruiting nowThis is the first study testing the experimental cancer drug ADCX-020 in people. Researchers will give increasing doses to 290 adults with advanced solid tumors that have spread or returned after standard treatments. The main goals are to find a safe dose and see early signs of w…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC